Kazia Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Kazia Therapeutics has a total shareholder equity of A$12.1M and total debt of A$1.8M, which brings its debt-to-equity ratio to 14.9%. Its total assets and total liabilities are A$28.1M and A$16.0M respectively.
Key information
14.9%
Debt to equity ratio
AU$1.80m
Debt
Interest coverage ratio | n/a |
Cash | AU$5.24m |
Equity | AU$12.05m |
Total liabilities | AU$16.03m |
Total assets | AU$28.09m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: KZA's short term assets (A$10.8M) exceed its short term liabilities (A$7.6M).
Long Term Liabilities: KZA's short term assets (A$10.8M) exceed its long term liabilities (A$8.5M).
Debt to Equity History and Analysis
Debt Level: KZA has more cash than its total debt.
Reducing Debt: KZA's debt to equity ratio has increased from 0% to 14.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KZA has sufficient cash runway for 4 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: Insufficient data to determine if KZA has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.